You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 14, 2025

Drug Price Trends for AMLODIPINE-VALSARTAN


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for AMLODIPINE-VALSARTAN

Average Pharmacy Cost for AMLODIPINE-VALSARTAN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
AMLODIPINE-VALSARTAN 10-160 MG 23155-0845-03 0.47623 EACH 2024-12-18
AMLODIPINE-VALSARTAN 10-160 MG 62332-0206-30 0.47623 EACH 2024-12-18
AMLODIPINE-VALSARTAN 10-160 MG 62332-0206-90 0.47623 EACH 2024-12-18
AMLODIPINE-VALSARTAN 10-160 MG 23155-0845-09 0.47623 EACH 2024-12-18
AMLODIPINE-VALSARTAN-HYDROCHLOROTHIAZIDE 5-160-25 MG TAB 65862-0835-30 6.78193 EACH 2024-12-18
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Amlodipine-Valsartan

Introduction

Amlodipine-valsartan, a combination drug used to treat high blood pressure, is a significant player in the antihypertensive market. This analysis will delve into the current market trends, sales data, price projections, and forecasted growth for this medication.

Market Size and Growth

The global market for amlodipine-valsartan tablets has been growing steadily. As of 2023, the market was valued at US$ 420 million and is anticipated to reach US$ 696.8 million by 2030, with a Compound Annual Growth Rate (CAGR) of 7.5% during the forecast period of 2024-2030[4].

Sales Trends and Forecast

Historical sales data indicate that amlodipine-valsartan has seen consistent growth. The sales forecast suggests continued expansion, driven by increasing demand for effective antihypertensive treatments. The report from ResearchAndMarkets.com provides detailed sales forecasts by country, which is crucial for market planning, market sizing, and competitive intelligence[1].

Pricing Analysis

The pricing of amlodipine-valsartan varies based on the dosage and the pharmacy. For example, a 30-tablet supply of amlodipine-valsartan (10 mg-160 mg) can cost around $38.35, while a 30-tablet supply of amlodipine-valsartan (10 mg-320 mg) can cost approximately $45.45 for cash-paying customers[2].

Price Breakdown

  • 10 mg-160 mg: $38.35 for 30 tablets, with a per-unit price of $1.28[2].
  • 10 mg-320 mg: $45.45 for 30 tablets, with a per-unit price of $1.52[2].
  • 5 mg-160 mg: $34.23 for 30 tablets, with a per-unit price of $1.14[2].

Regional Market Analysis

The market for amlodipine-valsartan is segmented across various regions, including North America, Europe, Asia Pacific, South America, and the Middle East and Africa. Each region has its own market size, growth trends, and competitive landscape.

  • North America: This region is one of the largest markets for amlodipine-valsartan, driven by high healthcare spending and a large patient population.
  • Europe: Countries like Germany, France, and the UK contribute significantly to the European market.
  • Asia Pacific: This region is expected to see rapid growth due to increasing healthcare infrastructure and a growing patient base in countries like China and India[4].

Competitive Landscape

The market for amlodipine-valsartan is competitive, with several key players involved. These include:

  • Novartis Pharma: Known for its brand name Exforge.
  • Baiao Pharma
  • Brilliant Pharma
  • Hengrui Pharma
  • Huahai Pharma
  • Lepu Pharma
  • Wangao Pharma[4].

These companies compete on the basis of pricing, product quality, and market reach.

Technological Trends and New Product Developments

The antihypertensive market is continuously evolving with new product developments and technological advancements. For instance, the combination of amlodipine with other antihypertensive agents like hydrochlorothiazide (Exforge HCT) is gaining traction, offering more comprehensive treatment options for patients[5].

Market Segmentation

The global amlodipine-valsartan market is segmented by type and application:

  • By Type: Different dosages and combinations (e.g., Valsartan and Amlodipine Tablets I and II).
  • By Application: Hospital, clinic, and other healthcare settings[4].

Impact of COVID-19

The COVID-19 pandemic has highlighted the importance of robust healthcare systems and the need for effective treatments for chronic conditions like hypertension. This has led to increased demand for antihypertensive medications, including amlodipine-valsartan[4].

Price Projections

Given the forecasted growth rate of 7.5% from 2024 to 2030, the prices of amlodipine-valsartan are expected to remain competitive. However, prices may fluctuate based on factors such as production costs, regulatory changes, and market competition.

Future Pricing Scenarios

  • Short-term: Prices are likely to remain stable, with minor adjustments based on market dynamics.
  • Long-term: As the market grows, there could be slight increases in prices due to increased demand and potential supply chain costs[4].

Key Takeaways

  • The global amlodipine-valsartan market is projected to grow significantly, reaching US$ 696.8 million by 2030.
  • Pricing varies by dosage and region, with competitive pricing strategies in place.
  • The market is segmented by region, type, and application, with key players competing for market share.
  • Technological trends and new product developments are driving market growth.
  • The COVID-19 pandemic has emphasized the need for effective antihypertensive treatments.

FAQs

What is the current market size of amlodipine-valsartan tablets?

The global market for amlodipine-valsartan tablets was valued at US$ 420 million in 2023[4].

What is the forecasted growth rate for the amlodipine-valsartan market?

The market is expected to grow at a CAGR of 7.5% from 2024 to 2030[4].

Which regions are the largest markets for amlodipine-valsartan?

North America, Europe, and the Asia Pacific are among the largest markets for amlodipine-valsartan[4].

What are the brand names for amlodipine-valsartan?

The brand name for amlodipine-valsartan is Exforge[2].

How does the COVID-19 pandemic impact the amlodipine-valsartan market?

The pandemic has increased the demand for antihypertensive medications, including amlodipine-valsartan, due to the emphasis on managing chronic conditions during the health crisis[4].

Sources

  1. Business Wire: "2017 Amlodipine / Valsartan Sales, Price Analysis, & Sales Forecast - 2017"[1].
  2. Drugs.com: "Amlodipine/valsartan Prices, Coupons, Copay Cards & Patient Assistance"[2].
  3. iHealthcareAnalyst: "Antihypertensive Drugs Market and Forecast 2024-2031"[3].
  4. QYResearch: "Global Valsartan and Amlodipine Tablets Market Research Report 2024"[4].
  5. Drugs.com: "Amlodipine/hydrochlorothiazide/valsartan Prices, Coupons, Copay Cards & Patient Assistance"[5].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.